Medtronic's (NYSE:MDT) stand-alone diabetes company, first announced in May, will be known as MiniMed. MiniMed was the ...

Medtronic plc a global leader in medical technology, announced its intent to spin off its Diabetes business into a entity ...

CNW/ -- (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New ...

Image courtesy of Medtronic] The soon-to-be-separated Medtronic (NYSE: MDT) + Diabetes unit has a new — yet familiar — name, ...

Medtronic plc MDT announced on May 21 its plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction a ...

Medtronic, which announced last month it will spin off its $2.8 billion diabetes unit as a standalone public company, has ...

Medtronic’s decision to spin out its diabetes division into a separate entity marks a major shift — one that allows the medical device giant to shed a lower-margin, consumer-facing business ...

Medtronic PLC announced Wednesday plans to separate its diabetes business into a new public company, just as the medical-device company reported quarterly results showing that the business was its ...

The American Diabetes Association’s annual conference kicks off amid a dynamic year for diabetes tech, as access improves for ...

On May 21, Medtronic announced its intention to separate its Diabetes into an ... its stock price for the following reasons: The Diabetes business manufactures insulin pumps, sensors, continuous ...

Medical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a division that had struggled but recently returned to ...

Medtronic said. The diabetes business generated nearly $2.8 billion in sales in its most recent fiscal year, ending in April, up 10.7% from the prior year. Medtronic reported more than $34 billion ...